An Open-Label Trial of Donepezil in Fragile X Syndrome
NCT00220584
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Fragile X Syndrome
Interventions
DRUG:
donepezil
Sponsor
Stanford University